Clinical application of an antibiotic's pharmacokinetic/pharmacodynamic (PK/PD) properties may improve the outcome of severe infections. No data are available on the use of linezolid (LNZ) continuous infusion in critically ill obese patients affected by ventilator-associated pneumonia (VAP).
Original languageEnglish
Pages (from-to)103-110
Number of pages8
JournalIntensive Care Medicine
Publication statusPublished - 2015


  • Acetamides
  • Aged
  • Anti-Bacterial Agents
  • Critical Illness
  • Drug Monitoring
  • Female
  • Humans
  • Infusions, Intravenous
  • Linezolid
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Obesity
  • Organ Dysfunction Scores
  • Oxazolidinones
  • Pneumonia, Ventilator-Associated
  • Prospective Studies
  • Risk Assessment
  • Rome


Dive into the research topics of 'Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration'. Together they form a unique fingerprint.

Cite this